Chemotherapy-induced peripheral neurotoxicity: a critical analysis
- PMID: 24590861
- DOI: 10.3322/caac.21204
Chemotherapy-induced peripheral neurotoxicity: a critical analysis
Abstract
With a 3-fold increase in the number of cancer survivors noted since the 1970s, there are now over 28 million cancer survivors worldwide. Accordingly, there is a heightened awareness of long-term toxicities and the impact on quality of life following treatment in cancer survivors. This review will address the increasing importance and challenge of chemotherapy-induced neurotoxicity, with a focus on neuropathy associated with the treatment of breast cancer, colorectal cancer, testicular cancer, and hematological cancers. An overview of the diagnosis, symptomatology, and pathophysiology of chemotherapy-induced peripheral neuropathy will be provided, with a critical analysis of assessment strategies, neuroprotective approaches, and potential treatments. The review will concentrate on neuropathy associated with taxanes, platinum compounds, vinca alkaloids, thalidomide, and bortezomib, providing clinical information specific to these chemotherapies.
Keywords: chemotherapy; neuropathy; neurotoxicity; survivorship.
© 2013 American Cancer Society, Inc.
Similar articles
-
Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies.Neth J Med. 2012 Jan;70(1):18-25. Neth J Med. 2012. PMID: 22271810 Review.
-
Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies.Curr Med Chem. 2008;15(29):3081-94. doi: 10.2174/092986708786848569. Curr Med Chem. 2008. PMID: 19075655 Review.
-
Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.JAMA Neurol. 2018 Aug 1;75(8):980-988. doi: 10.1001/jamaneurol.2018.0963. JAMA Neurol. 2018. PMID: 29799906 Free PMC article.
-
Nerve excitability assessment in chemotherapy-induced neurotoxicity.J Vis Exp. 2012 Apr 26;(62):3439. doi: 10.3791/3439. J Vis Exp. 2012. PMID: 22565594 Free PMC article.
-
Quantification of Small Fiber Neuropathy in Chemotherapy-Treated Patients.J Pain. 2020 Jan-Feb;21(1-2):44-58. doi: 10.1016/j.jpain.2019.06.011. Epub 2019 Jul 17. J Pain. 2020. PMID: 31325646 Review.
Cited by
-
Peripheral Neuropathy under Oncologic Therapies: A Literature Review on Pathogenetic Mechanisms.Int J Mol Sci. 2021 Feb 17;22(4):1980. doi: 10.3390/ijms22041980. Int J Mol Sci. 2021. PMID: 33671327 Free PMC article. Review.
-
Pharmacovigilance study of the association between peripheral neuropathy and antibody-drug conjugates using the FDA adverse event reporting system.Sci Rep. 2024 Sep 13;14(1):21386. doi: 10.1038/s41598-024-71977-0. Sci Rep. 2024. PMID: 39271716 Free PMC article.
-
A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).Support Care Cancer. 2017 Jan;25(1):195-204. doi: 10.1007/s00520-016-3404-y. Epub 2016 Sep 9. Support Care Cancer. 2017. PMID: 27612466 Clinical Trial.
-
Pathological Mechanisms and Preventive Strategies of Oxaliplatin-Induced Peripheral Neuropathy.Front Pain Res (Lausanne). 2021 Dec 8;2:804260. doi: 10.3389/fpain.2021.804260. eCollection 2021. Front Pain Res (Lausanne). 2021. PMID: 35295491 Free PMC article. Review.
-
IMPACT OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY ON THE QUALITY OF LIFE IN CANCER PATIENTS.Acta Clin Croat. 2022 Mar;61(1):52-61. doi: 10.20471/acc.2022.61.01.07. Acta Clin Croat. 2022. PMID: 36530966 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical